PCVX — VAXCYTE INC

Ownership history in Entropy Technologies, LP  ·  2 quarters on record

This page tracks every 13F SEC filing in which Entropy Technologies, LP reported a position in VAXCYTE INC (PCVX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.04% (2025 Q3)
Avg. % of fund
0.04%
First filed
2025 Q2
Last filed
2025 Q3
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 15,638 +3,263 +26.4% 0.04% $563K $36.02
2025 Q2 INITIATED 12,375 — — 0.03% $402K $32.51
% of Fund (quarterly)    PCVX price (monthly, adj. close)

Other funds also holding PCVX

As of 2025 Q4 — sorted by position size

Pivotal bioVenture Partners Investment Advisor LLC 3Y 24.48% Kynam Capital Management, LP 3Y 8.61% Saturn V Capital Management LP 3Y 6.77% Caligan Partners LP 3Y 6.48% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 5.07% Paradigm Biocapital Advisors LP 3Y 4.79% Elmind Capital, LP 3.97% Deep Track Capital, LP 3Y 3.29% Novo Holdings A/S 3Y 7Y 3.28% Eversept Partners, LP 3Y 7Y 2.78%
← Back to Entropy Technologies, LP Holdings